PEPGEN INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
PEPGEN INC. (PEPG) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 6.26 million shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-04.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-03-04
- PEPGEN INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 6.26M shares, a 5.26% increase from fiscal 2024.
- PEPGEN INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 5.95M shares, a 40.47% increase from fiscal 2023.
- PEPGEN INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 4.23M shares, a 26.67% increase from fiscal 2022.
- PEPGEN INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 3.34M shares, a 77.03% decline from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | 6.26M shares 10-K · filed 2026-03-04 | |
| 2024-12-31 | 5.95M shares 10-K · filed 2026-03-04 | 5.85M shares 10-K · filed 2025-02-24 |
| 2023-12-31 | 4.23M shares 10-K · filed 2025-02-24 | |
| 2022-12-31 | 3.34M shares 10-K/A · filed 2024-03-29 | |
| 2021-12-31 | 14.55M shares 10-K · filed 2023-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |